331 related articles for article (PubMed ID: 15614426)
1. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
Srinivasan J; Schmidt WJ
J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
[TBL] [Abstract][Full Text] [Related]
2. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
Haapalinna A; Leino T; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
[TBL] [Abstract][Full Text] [Related]
3. Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 Oct; 154(2):353-63. PubMed ID: 15313023
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
Dickinson SL; Gadie B; Tulloch IF
Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
[TBL] [Abstract][Full Text] [Related]
5. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Srinivasan J; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
[TBL] [Abstract][Full Text] [Related]
6. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
Sindhu KM; Saravanan KS; Mohanakumar KP
Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
[TBL] [Abstract][Full Text] [Related]
7. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
8. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Alam M; Danysz W; Schmidt WJ; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Chopin P; Colpaert FC; Marien M
J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
[TBL] [Abstract][Full Text] [Related]
10. alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
Matsumoto K; Mizowaki M; Thongpraditchote S; Murakami Y; Watanabe H
Pharmacol Biochem Behav; 1997 Mar; 56(3):417-22. PubMed ID: 9077577
[TBL] [Abstract][Full Text] [Related]
11. Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
Kleven MS; Assié MB; Cosi C; Barret-Grévoz C; Newman-Tancredi A
Psychopharmacology (Berl); 2005 Feb; 177(4):373-80. PubMed ID: 15448976
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.
Mavridis M; Colpaert FC; Millan MJ
Brain Res; 1991 Oct; 562(2):216-24. PubMed ID: 1685341
[TBL] [Abstract][Full Text] [Related]
13. The effect of a subchronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamine.
Spooren WP; Waldmeier P; Gentsch C
J Neural Transm (Vienna); 1999; 106(9-10):825-33. PubMed ID: 10599865
[TBL] [Abstract][Full Text] [Related]
14. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J; Overø KF; Hyttel J; Olsen R
Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
[TBL] [Abstract][Full Text] [Related]
15. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
[TBL] [Abstract][Full Text] [Related]
16. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
[TBL] [Abstract][Full Text] [Related]
17. The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of d-amphetamine-induced behavioural sensitization.
Juhila J; Haapalinna A; Sirviö J; Sallinen J; Honkanen A; Korpi ER; Scheinin M
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):274-80. PubMed ID: 12644900
[TBL] [Abstract][Full Text] [Related]
18. Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms.
West WB; Van Groll BJ; Appel JB
Pharmacol Biochem Behav; 1995 May; 51(1):69-76. PubMed ID: 7617735
[TBL] [Abstract][Full Text] [Related]
19. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.
Boules M; Warrington L; Fauq A; McCormick D; Richelson E
Eur J Pharmacol; 2001 Oct; 428(2):227-33. PubMed ID: 11675040
[TBL] [Abstract][Full Text] [Related]
20. Effects of adrenoceptor agents on apomorphine-induced licking behavior in rats.
Zarrindast MR; Fazli-Tabaei S; Semnanian S; Fathollah Y; Yahyavi SH
Pharmacol Biochem Behav; 2000 Feb; 65(2):275-9. PubMed ID: 10672980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
